STOCK TITAN

Biora Therapeutics, Inc. - BIOR STOCK NEWS

Welcome to our dedicated news page for Biora Therapeutics (Ticker: BIOR), a resource for investors and traders seeking the latest updates and insights on Biora Therapeutics .

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Biora Therapeutics 's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Biora Therapeutics 's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.44%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.3%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.96%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
31.17%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.57%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.15%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.6%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.35%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.32%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.6%
Tags
none
Biora Therapeutics, Inc.

Nasdaq:BIOR

BIOR Rankings

BIOR Stock Data

23.04M
13.75M
7.91%
64.14%
4.42%
Medical Laboratories
Health Care and Social Assistance
Link
United States of America
SAN DIEGO

About BIOR

progenity helps patients and their families prepare for life, with medically relevant health information starting before conception, through pregnancy, childhood, and adulthood. using our highly-complex molecular diagnostic testing, healthcare providers can access the most advanced genomic technology to guide patient care at critical life stages.